Lixisenatide
Lixisenatide (trade name Lyxumia in the European Union and Adlyxin in the U.S. and manufactured by Sanofi) is a once-daily injectable GLP-1 receptor agonist for the treatment of type 2 diabetes.
product
Wikipage redirect
primaryTopic
Lixisenatide
Lixisenatide (trade name Lyxumia in the European Union and Adlyxin in the U.S. and manufactured by Sanofi) is a once-daily injectable GLP-1 receptor agonist for the treatment of type 2 diabetes.
has abstract
Lixisenatide (trade name Lyxum ...... treatment of type 2 diabetes.
@en
Lixisenatide es un medicamento ...... os el 1 de febrero de 2013.
@es
リキシセナチド(lixisenatide)とはサノフィがZe ...... 増加が懸念された他、動物実験においても催奇形性が観察された。
@ja
alternative name
Lyxumia (EU), Adlyxin (US)
@en
CAS number
320367-13-3
ChEBI
ChEMBL
DrugBank
FDA UNII code
74O62BB01U
KEGG
MedlinePlus
PubChem
Link from a Wikipage to an external page
Wikipage page ID
28,932,220
page length (characters) of wiki page
Wikipage revision ID
1,022,209,306
Link from a Wikipage to another Wikipage
ATC prefix
A10
@en
ATC suffix
BJ03
@en
CAS number
ChEBI
ChEMBL
ChemSpiderID
17,295,846
DailyMedID
Lixisenatide
@en
DrugBank
DB09265
@en
IUPHAR ligand
KEGG
D09729
@en
legal EU
Rx-only
@en
legal UK
POM
@en
legal US
Rx-only
@en
licence EU
yes
@en
MedlinePlus
a617005
@en
pregnancy AU
B3
@en
pregnancy US
N
@en
PubChem
90,472,060
routes of administration
SMILES
CCCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCNCCN
@en
StdInChIKey
XVVOERDUTLJJHN-IAEQDCLQSA-N
@en
tradename
Lyxumia , Adlyxin
@en
wikiPageUsesTemplate
hypernym
comment
Lixisenatide (trade name Lyxum ...... treatment of type 2 diabetes.
@en
Lixisenatide es un medicamento ...... os el 1 de febrero de 2013.
@es
リキシセナチド(lixisenatide)とはサノフィがZe ...... 増加が懸念された他、動物実験においても催奇形性が観察された。
@ja
label
Lixisenatida
@es
Lixisenatide
@en
リキシセナチド
@ja